Cynthia Lynn Anderson - 30 Jun 2025 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Cynthia Anderson
Issuer symbol
VTGN
Transactions as of
30 Jun 2025
Net transactions value
+$11,249
Form type
4
Filing time
01 Jul 2025, 17:49:44 UTC
Previous filing
25 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Cynthia Anderson 01 Jul 2025 0001989905

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $11,249 +6,617 +107% $1.70 12,801 30 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).